查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1371963

到 2030 年精准医疗人工智慧市场预测：按产品、技术、用途和区域分析全球市场

Artificial Intelligence In Precision Medicine Market Forecasts to 2030 - Global Analysis By Offering, Technology, Application and By Geography.
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球精准医疗人工智慧市场规模为 17.3 亿美元，预测期内年复合成长率为 33.8%，到 2030 年将达到 133 亿美元。

精准医疗中的人工智慧 (AI) 涉及使用个人基因组资料来开发个人化医疗。这些资料使得为患者制定治疗计划成为可能。医疗保健中的人工智慧（AI）用于借助演算法和软体模拟人类认知来分析复杂的医疗资料。人工智慧技术预计将有助于使这一过程更快、更便宜，从而提高製药和生物技术公司的效率。

根据美国国立卫生研究院（NIH）的报告，2023年，光是美国就将新增190万癌症病例，609,820人死亡。因此，人工智慧在肿瘤学中的整合有望有助于更准确、更快速地诊断癌症，从而改善患者的治疗结果。

癌症患病增加

癌症罹患率持续上升，需要更有效和精确的治疗策略。人工智慧凭藉其先进的演算法和机器学习能力，已成为解决癌症诊断、预后和个体化治疗复杂性的强大工具。人工智慧透过影像分析对癌症诊断产生重大影响，有助于高度准确地早期检测癌症和转移。此外，人工智慧主导的预测模型可以帮助预测疾病结果和患者对各种治疗的反应，从而促进客製化和最佳化的治疗方法。人工智慧将确保患者接受最合适、最有效的治疗，最终提高存活率并提高癌症护理的整体品质。

高成本

开发和部署精准医疗人工智慧技术需要大量成本，包括研究、资料收集、演算法开发、运算资源和专业知识。成本集中流程包括建置和维护最先进的运算基础设施、评估大量医疗资料以及开发人工智慧模型。这些经济障碍对可近性和可负担性提出了挑战，限制了人工智慧在精准医疗中的普及和实施，并最终限制了其彻底改变医疗保健结果和个体化治疗的潜力。

技术进步

人工智慧取得了显着的进步，利用机器学习、深度学习、自然语言处理和预测分析彻底改变了精准医疗背景下医疗资料的分析和使用方式。人工智慧驱动的工具可以协助诊断、药物研发、患者风险评估和治疗最佳化，以改善患者照护和结果。此外，人工智慧演算法和模型的不断增强，有助于为精准医疗创建更准确、高效、可靠的人工智慧解决方案。随着技术的不断发展，人工智慧在精准医疗方面的能力将进一步扩展，有助于更有效、及时和个体化的医疗干预，最终彻底改变医疗保健的实践方式并达到全球范围，有望改善患者的治疗结果。

安全风险

人工智慧整合需要大量患者特定资讯，包括遗传资料和医疗记录。如此丰富的个人资料使该领域成为网路威胁、资料外洩和诈欺存取的有吸引力的目标。保护此类敏感资讯免受恶意攻击并确保遵守严格的隐私法规是一项重大挑战。安全漏洞损害了患者的机密性，并削弱了对人工智慧系统的信任，可能会阻碍医疗保健提供者和患者采用这些潜在的变革性技术。这些威胁正在阻碍市场成长。

COVID-19 的影响

COVID-19的爆发对精准医疗市场的人工智慧产生了积极影响。医疗保健部门越来越注重利用人工智慧技术来应对疫情带来的挑战。在 COVID-19 危机期间，人工智慧在诊断、治疗方法开发、新药发现和患者管理领域变得至关重要。此外，人工智慧演算法的使用可以分析大量资料库，从而准确、快速地诊断 COVID-19 病例。人工智慧驱动的解决方案正在透过识别候选药物并加速药物再利用过程来加速潜在疗法和疫苗的开发，从而创造有希望的机会。

软体部分预计将在预测期内成为最大的部分

随着基于人工智慧的精准医疗软体解决方案被组织、医疗保健付款人、患者和医疗保健提供者迅速采用，软体领域预计将占据最大份额。人工智慧技术在医疗保健行业的不断增长的应用也要素了成长，包括远端医疗、机器人手术、临床试验、给药、减少管理错误、虚拟助理和临床试验。此外，政府和商业性配合措施也正在推动这一领域的扩张。有几家公司提供软体服务，使用基于科学预测的深入知识的机器学习演算法来估计癌症进展，从而可以有效预测治疗后的癌症进展。这很有帮助。

神经病学领域预计在预测期内年复合成长率最高

由于癫痫、失智症、失智症、阿兹海默症和脑肿瘤等神经系统疾病的患病不断上升，预计神经病学领域将在预测期内出现良好的增长。这一领域的成长也推动了对人工智慧不断增长的需求，人工智慧可以透过提供精准治疗来治疗罹患患者。人工智慧增强了神经外科的术前、术后和术中阶段。这些因素正在推动该领域的成长。

比最大的地区

北美地区在健康福祉方面消费者消费能力强劲，研发相关投资增长迅速，美国、加拿大等国家医疗基础设施强大，2022年精准医疗获得最大市场占有率由于其在人工智能市场的主导地位，在预测期内。此外，几家知名人工智慧软体和系统製造商的出现，以及政府配合措施支持新创公司使用人工智慧，可能会加速该领域的成长。

复合年复合成长率最高的地区：

预计欧洲在预测期内将出现盈利成长。慢性病发病率的增加和老年人口的增加增加了对感染疾病的早期发现和强制执行的需求。该地区国家正在积极采用人工智慧技术来改善医疗保健结果。人工智慧被用来解释大量的医疗资料集、个体化治疗和最佳化药物研发过程。许多公司正在实施策略来获得相对于竞争对手的竞争优势。此外，学术界、工业界和医疗保健提供者之间的配合措施正在推动人工智慧在精准医疗领域的发展，使欧洲成为这个变革性医疗保健领域的关键参与者。

提供免费客製化：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和年复合成长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

  • 概述
  • 利害关係人
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第3章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 技术分析
  • 应用分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第5章精准医疗市场中的全球人工智慧：依产品分类

  • 硬体
  • 服务
  • 软体

第6章全球人工智慧精准医疗市场：依技术分类

  • 机器学习
  • 情境感知计算
  • 自然语言处理
  • 电脑视觉
  • 如何联络方式
  • 深度学习

第7章全球人工智慧在精准医疗市场：依应用分类

  • 肿瘤学
  • 神经病学
  • 心臟病学
  • 呼吸系统
  • 眼科
  • 肾臟病学
  • 耳鼻喉科
  • 其他用途

第8章全球人工智慧精准医疗市场：按地区划分

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第9章进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第10章公司简介

  • BioXcel Therapeutics Inc.
  • Intel Corporation
  • Insilico Medicine
  • Microsoft Corporation
  • NVIDIA Corporation
  • Sensely, Inc.
  • Alphabet Inc.（Google）
  • IBM
  • AceTech
  • Enlitic Inc
  • GE Healthcare
  • AstraZeneca
  • Sanofi
  • Microsoft Corporation
  • Welletok Inc.
  • General Vision
  • Atomwise Inc.
  • Caption Health
  • Zephyr AI
  • Berg Health
Product Code: SMRC24020

According to Stratistics MRC, the Global Artificial Intelligence In Precision Medicine Market is accounted for $1.73 billion in 2023 and is expected to reach $13.3 billion by 2030 growing at a CAGR of 33.8% during the forecast period. Artificial intelligence (AI) in precision medicine involves the use of genomic data about an individual to develop personalised medicine. With this data, it is possible to create treatment plans for patients. Artificial intelligence (AI) in medicine is used to analyse complex medical data by approximating human cognition with the help of algorithms and software. AI technology can help make this process faster and cheaper, which in turn is expected to improve the efficiency of pharmaceutical and biotechnology companies.

According to the National Institutes of Health (NIH) report, in 2023, 1.9 million new cancer cases and 609,820 cancer deaths are projected to occur in the U.S. only. Therefore, integration of AI in oncology is expected to contribute to more accurate and faster diagnosis of cancer, leading to enhanced patient outcomes.

Market Dynamics:

Driver:

Increasing prevalence of cancer

Cancer incidence rates continue to escalate, necessitating more effective and precise treatment strategies. AI, with its advanced algorithms and machine learning capabilities, has emerged as a potent tool to tackle the complexities of cancer diagnosis, prognosis, and personalised treatment. AI has a significant impact on the diagnosis of cancer through image analysis, assisting in the very accurate early detection of cancers and metastases. Moreover, AI-driven predictive modelling helps anticipate disease outcomes and patient responses to various treatments, facilitating tailored and optimised therapeutic approaches. AI ensures that patients receive the most appropriate and effective treatments, ultimately improving survival rates and enhancing the overall quality of cancer care.

Restraint:

High cost

The development and deployment of AI technologies for precision medicine entail substantial expenses in terms of research, data collection, algorithm development, computational resources, and specialised expertise. The cost-intensive processes include building and maintaining cutting-edge computing infrastructure, evaluating vast amounts of healthcare data, and developing AI models. These financial barriers pose challenges in accessibility and affordability, limiting the widespread adoption and implementation of AI in precision medicine and ultimately affecting its potential to revolutionise healthcare outcomes and personalised treatments.

Opportunity:

Technological advancements

AI has evolved with remarkable progress, leveraging machine learning, deep learning, natural language processing, and predictive analytics to revolutionise how medical data is analysed and utilised in the context of precision medicine. AI-powered tools can assist in diagnosis, drug discovery, patient risk assessment, and treatment optimisation, enhancing overall patient care and outcomes. Moreover, the continuous enhancement of AI algorithms and models is fostering the creation of more accurate, efficient, and reliable AI solutions for precision medicine. As technology continues to evolve, the capabilities of AI in precision medicine are expected to expand further, contributing to more effective, timely, and personalised healthcare interventions, ultimately revolutionising the way medicine is practiced and improving patient outcomes on a global scale.

Threat:

Security risks

The integration of AI requires vast amounts of patient-specific information, including genetic data and medical records. This abundance of personal data makes the sector a prime target for cyber threats, data breaches, and unauthorised access. Protecting this sensitive information from malicious attacks and ensuring compliance with stringent privacy regulations poses a significant challenge. Security breaches can compromise patient confidentiality, erode trust in AI-powered systems, and deter both healthcare providers and patients from adopting these potentially transformative technologies. These threats are hampering market growth.

COVID-19 Impact

The COVID-19 pandemic had a positive impact on AI in the precision medicine market. The healthcare sector had noticed a greater focus on using AI technologies to deal with the problems the pandemic had brought up. During the COVID-19 crisis, AI was essential in areas including diagnosis, the development of treatments, the discovery of new drugs, and patient management. Additionally, the use of AI algorithms has made it possible to analyse huge databases for a precise and quick diagnosis of COVID-19 cases. AI-powered solutions have facilitated the development of potential therapeutics and vaccines by identifying drug candidates and expediting the drug repurposing process, this has produced promising opportunities.

The Software segment is expected to be the largest during the forecast period

The Software segment is estimated to hold the largest share, due to a rapid adoption of software solutions based on artificial intelligence in precision medicine by organisations, healthcare payers, patients, and providers. The growth is also attributable to the expanding applications of AI technology in the healthcare industry, including telemedicine, robotic surgery, clinical trials, cybersecurity, dosing error reduction, virtual assistants, and clinical trials. Additionally, government and commercial initiatives also fuel the segment's expansion. Several companies provide software services that estimate cancer progression using an ML algorithm based on in-depth knowledge of scientific prediction, helping to effectively anticipate cancer progression as a response to therapy.

The Neurology segment is expected to have the highest CAGR during the forecast period

The Neurology segment is anticipated to have lucrative growth during the forecast period, due to the rising prevalence of neurological conditions such as epilepsy, dementia, migraines, Alzheimer's, and brain tumours. Growth in the sector is also being fuelled as rising demand for artificial intelligence which is able to treat patients affected by strokes by providing precision treatment. AI enhances brain surgery's preoperative, postoperative, and intraoperative phases. These elements are propelling segment growth.

Region with largest share:

North America commanded the largest market share during the extrapolated period due to the region's high consumer spending power on their health and well-being, rapid growth in investment associated with research and development-related activities, the presence of a strong healthcare infrastructure in countries like the United States and Canada, and its dominance in the market for artificial intelligence in precision medicine in 2022. Moreover, the existence of multiple well-known manufacturers of AI software and systems, as well as greater government initiatives to support start-up's usage of AI, will also hasten the growth of the sector.

Region with highest CAGR:

Europe is expected to witness profitable growth over the projection period. The need for enhancing and discovering infections in their early stages is rising as a result of the rising frequency of chronic diseases and the growing older population. Countries within the region are actively embracing AI technologies to enhance healthcare outcomes. AI is being utilised to interpret vast medical datasets, personalise treatments, and optimise drug discovery processes. Various companies are implementing strategies to gain a competitive advantage over others. Additionally, collaborative efforts among academia, industry, and healthcare providers are fostering the growth of AI in precision medicine, positioning Europe as a key player in this transformative healthcare domain.

Key players in the market:

Some of the key players in the Artificial Intelligence In Precision Medicine Market include: BioXcel Therapeutics Inc., Intel Corporation, Insilico Medicine, Microsoft Corporation, NVIDIA Corporation, Sensely, Inc., Alphabet Inc. (Google), IBM, AceTech, Enlitic Inc, GE Healthcare, AstraZeneca, Sanofi, Microsoft Corporation, Welletok Inc., General Vision, Atomwise Inc., Caption Health, Zephyr AI and Berg Health .

Key Developments:

In March 2023, Enlitic, Inc. announced the launch of Enlitic Curie 1.3, an AI-based platform that hosts Curie|ENCOG and Curie|ENDEX applications. This launch makes it easier for radiology departments to improve department-wide workflows.

In November 2022, Google partnered with iCAD, Inc. The collaboration aims to improve breast cancer detection and risk assessment in the short term. Furthermore, the partnership would focus on increasing connectivity to mammography technology via cloud-based solutions.

In September 2022, NVIDIA announced collaboration with Harvard and MIT's Broad Institute. By bringing NVIDIA's computing and AI tools to the institute's Terra cloud platform, the partnership aims to assist academic researchers and pharmaceutical companies in gaining AI-enabled computing power to extract large quantities of healthcare data.

In September 2022, GE Healthcare launched an artificial intelligence-powered Cath lab, Optima IGS 320. The release is expected to offer intelligent imaging to assist patients and cardiologists with personalized therapy protocols.

In August 2022, Sanofi and Atomwise joined a partnership. As per this collaboration, the companies targeted to make the development of drug discovery more cost-effective and effective.

Offerings Covered:

  • Hardware
  • Services
  • Software

Technologies Covered:

  • Machine Learning
  • Context-aware Computing
  • Natural Language Processing
  • Computer Vision
  • Querying Method
  • Deep Learning

Applications Covered:

  • Oncology
  • Neurology
  • Cardiology
  • Respiratory
  • Ophthalmology
  • Nephrology
  • Otorhinolaryngology
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Artificial Intelligence In Precision Medicine Market, By Offering

  • 5.1 Introduction
  • 5.2 Hardware
  • 5.3 Services
  • 5.4 Software

6 Global Artificial Intelligence In Precision Medicine Market, By Technology

  • 6.1 Introduction
  • 6.2 Machine Learning
  • 6.3 Context-aware Computing
  • 6.4 Natural Language Processing
  • 6.5 Computer Vision
  • 6.6 Querying Method
  • 6.7 Deep Learning

7 Global Artificial Intelligence In Precision Medicine Market, By Application

  • 7.1 Introduction
  • 7.2 Oncology
  • 7.3 Neurology
  • 7.4 Cardiology
  • 7.5 Respiratory
  • 7.6 Ophthalmology
  • 7.7 Nephrology
  • 7.8 Otorhinolaryngology
  • 7.9 Other Applications

8 Global Artificial Intelligence In Precision Medicine Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 BioXcel Therapeutics Inc.
  • 10.2 Intel Corporation
  • 10.3 Insilico Medicine
  • 10.4 Microsoft Corporation
  • 10.5 NVIDIA Corporation
  • 10.6 Sensely, Inc.
  • 10.7 Alphabet Inc. (Google)
  • 10.8 IBM
  • 10.9 AceTech
  • 10.10 Enlitic Inc
  • 10.11 GE Healthcare
  • 10.12 AstraZeneca
  • 10.13 Sanofi
  • 10.14 Microsoft Corporation
  • 10.15 Welletok Inc.
  • 10.16 General Vision
  • 10.17 Atomwise Inc.
  • 10.18 Caption Health
  • 10.19 Zephyr AI
  • 10.20 Berg Health

List of Tables

  • Table 1 Global Artificial Intelligence In Precision Medicine Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Artificial Intelligence In Precision Medicine Market Outlook, By Offering
  • Table 3 Global Artificial Intelligence In Precision Medicine Market Outlook, By Hardware
  • Table 4 Global Artificial Intelligence In Precision Medicine Market Outlook, By Services
  • Table 5 Global Artificial Intelligence In Precision Medicine Market Outlook, By Software
  • Table 6 Global Artificial Intelligence In Precision Medicine Market Outlook, By Technology
  • Table 7 Global Artificial Intelligence In Precision Medicine Market Outlook, By Machine Learning
  • Table 8 Global Artificial Intelligence In Precision Medicine Market Outlook, By Context-aware Computing
  • Table 9 Global Artificial Intelligence In Precision Medicine Market Outlook, By Natural Language Processing
  • Table 10 Global Artificial Intelligence In Precision Medicine Market Outlook, By Computer Vision
  • Table 11 Global Artificial Intelligence In Precision Medicine Market Outlook, By Querying Method
  • Table 12 Global Artificial Intelligence In Precision Medicine Market Outlook, By Deep Learning
  • Table 13 Global Artificial Intelligence In Precision Medicine Market Outlook, By Application
  • Table 14 Global Artificial Intelligence In Precision Medicine Market Outlook, By Oncology
  • Table 15 Global Artificial Intelligence In Precision Medicine Market Outlook, By Neurology
  • Table 16 Global Artificial Intelligence In Precision Medicine Market Outlook, By Cardiology
  • Table 17 Global Artificial Intelligence In Precision Medicine Market Outlook, By Respiratory
  • Table 18 Global Artificial Intelligence In Precision Medicine Market Outlook, By Ophthalmology
  • Table 19 Global Artificial Intelligence In Precision Medicine Market Outlook, By Nephrology
  • Table 20 Global Artificial Intelligence In Precision Medicine Market Outlook, By Otorhinolaryngology
  • Table 21 Global Artificial Intelligence In Precision Medicine Market Outlook, By Other Applications
  • Table 22 North America Artificial Intelligence In Precision Medicine Market Outlook, By Country (2021-2030) ($MN)
  • Table 23 North America Artificial Intelligence In Precision Medicine Market Outlook, By Offering (2021-2030) ($MN)
  • Table 24 North America Artificial Intelligence In Precision Medicine Market Outlook, By Hardware (2021-2030) ($MN)
  • Table 25 North America Artificial Intelligence In Precision Medicine Market Outlook, By Services (2021-2030) ($MN)
  • Table 26 North America Artificial Intelligence In Precision Medicine Market Outlook, By Software (2021-2030) ($MN)
  • Table 27 North America Artificial Intelligence In Precision Medicine Market Outlook, By Technology (2021-2030) ($MN)
  • Table 28 North America Artificial Intelligence In Precision Medicine Market Outlook, By Machine Learning (2021-2030) ($MN)
  • Table 29 North America Artificial Intelligence In Precision Medicine Market Outlook, By Context-aware Computing (2021-2030) ($MN)
  • Table 30 North America Artificial Intelligence In Precision Medicine Market Outlook, By Natural Language Processing (2021-2030) ($MN)
  • Table 31 North America Artificial Intelligence In Precision Medicine Market Outlook, By Computer Vision (2021-2030) ($MN)
  • Table 32 North America Artificial Intelligence In Precision Medicine Market Outlook, By Querying Method (2021-2030) ($MN)
  • Table 33 North America Artificial Intelligence In Precision Medicine Market Outlook, By Deep Learning (2021-2030) ($MN)
  • Table 34 North America Artificial Intelligence In Precision Medicine Market Outlook, By Application (2021-2030) ($MN)
  • Table 35 North America Artificial Intelligence In Precision Medicine Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 36 North America Artificial Intelligence In Precision Medicine Market Outlook, By Neurology (2021-2030) ($MN)
  • Table 37 North America Artificial Intelligence In Precision Medicine Market Outlook, By Cardiology (2021-2030) ($MN)
  • Table 38 North America Artificial Intelligence In Precision Medicine Market Outlook, By Respiratory (2021-2030) ($MN)
  • Table 39 North America Artificial Intelligence In Precision Medicine Market Outlook, By Ophthalmology (2021-2030) ($MN)
  • Table 40 North America Artificial Intelligence In Precision Medicine Market Outlook, By Nephrology (2021-2030) ($MN)
  • Table 41 North America Artificial Intelligence In Precision Medicine Market Outlook, By Otorhinolaryngology (2021-2030) ($MN)
  • Table 42 North America Artificial Intelligence In Precision Medicine Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 43 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Country (2021-2030) ($MN)
  • Table 44 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Offering (2021-2030) ($MN)
  • Table 45 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Hardware (2021-2030) ($MN)
  • Table 46 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Services (2021-2030) ($MN)
  • Table 47 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Software (2021-2030) ($MN)
  • Table 48 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Technology (2021-2030) ($MN)
  • Table 49 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Machine Learning (2021-2030) ($MN)
  • Table 50 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Context-aware Computing (2021-2030) ($MN)
  • Table 51 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Natural Language Processing (2021-2030) ($MN)
  • Table 52 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Computer Vision (2021-2030) ($MN)
  • Table 53 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Querying Method (2021-2030) ($MN)
  • Table 54 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Deep Learning (2021-2030) ($MN)
  • Table 55 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Application (2021-2030) ($MN)
  • Table 56 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 57 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Neurology (2021-2030) ($MN)
  • Table 58 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Cardiology (2021-2030) ($MN)
  • Table 59 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Respiratory (2021-2030) ($MN)
  • Table 60 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Ophthalmology (2021-2030) ($MN)
  • Table 61 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Nephrology (2021-2030) ($MN)
  • Table 62 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Otorhinolaryngology (2021-2030) ($MN)
  • Table 63 Europe Artificial Intelligence In Precision Medicine Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 64 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Country (2021-2030) ($MN)
  • Table 65 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Offering (2021-2030) ($MN)
  • Table 66 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Hardware (2021-2030) ($MN)
  • Table 67 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Services (2021-2030) ($MN)
  • Table 68 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Software (2021-2030) ($MN)
  • Table 69 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Technology (2021-2030) ($MN)
  • Table 70 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Machine Learning (2021-2030) ($MN)
  • Table 71 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Context-aware Computing (2021-2030) ($MN)
  • Table 72 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Natural Language Processing (2021-2030) ($MN)
  • Table 73 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Computer Vision (2021-2030) ($MN)
  • Table 74 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Querying Method (2021-2030) ($MN)
  • Table 75 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Deep Learning (2021-2030) ($MN)
  • Table 76 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Application (2021-2030) ($MN)
  • Table 77 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 78 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Neurology (2021-2030) ($MN)
  • Table 79 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Cardiology (2021-2030) ($MN)
  • Table 80 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Respiratory (2021-2030) ($MN)
  • Table 81 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Ophthalmology (2021-2030) ($MN)
  • Table 82 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Nephrology (2021-2030) ($MN)
  • Table 83 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Otorhinolaryngology (2021-2030) ($MN)
  • Table 84 Asia Pacific Artificial Intelligence In Precision Medicine Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 85 South America Artificial Intelligence In Precision Medicine Market Outlook, By Country (2021-2030) ($MN)
  • Table 86 South America Artificial Intelligence In Precision Medicine Market Outlook, By Offering (2021-2030) ($MN)
  • Table 87 South America Artificial Intelligence In Precision Medicine Market Outlook, By Hardware (2021-2030) ($MN)
  • Table 88 South America Artificial Intelligence In Precision Medicine Market Outlook, By Services (2021-2030) ($MN)
  • Table 89 South America Artificial Intelligence In Precision Medicine Market Outlook, By Software (2021-2030) ($MN)
  • Table 90 South America Artificial Intelligence In Precision Medicine Market Outlook, By Technology (2021-2030) ($MN)
  • Table 91 South America Artificial Intelligence In Precision Medicine Market Outlook, By Machine Learning (2021-2030) ($MN)
  • Table 92 South America Artificial Intelligence In Precision Medicine Market Outlook, By Context-aware Computing (2021-2030) ($MN)
  • Table 93 South America Artificial Intelligence In Precision Medicine Market Outlook, By Natural Language Processing (2021-2030) ($MN)
  • Table 94 South America Artificial Intelligence In Precision Medicine Market Outlook, By Computer Vision (2021-2030) ($MN)
  • Table 95 South America Artificial Intelligence In Precision Medicine Market Outlook, By Querying Method (2021-2030) ($MN)
  • Table 96 South America Artificial Intelligence In Precision Medicine Market Outlook, By Deep Learning (2021-2030) ($MN)
  • Table 97 South America Artificial Intelligence In Precision Medicine Market Outlook, By Application (2021-2030) ($MN)
  • Table 98 South America Artificial Intelligence In Precision Medicine Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 99 South America Artificial Intelligence In Precision Medicine Market Outlook, By Neurology (2021-2030) ($MN)
  • Table 100 South America Artificial Intelligence In Precision Medicine Market Outlook, By Cardiology (2021-2030) ($MN)
  • Table 101 South America Artificial Intelligence In Precision Medicine Market Outlook, By Respiratory (2021-2030) ($MN)
  • Table 102 South America Artificial Intelligence In Precision Medicine Market Outlook, By Ophthalmology (2021-2030) ($MN)
  • Table 103 South America Artificial Intelligence In Precision Medicine Market Outlook, By Nephrology (2021-2030) ($MN)
  • Table 104 South America Artificial Intelligence In Precision Medicine Market Outlook, By Otorhinolaryngology (2021-2030) ($MN)
  • Table 105 South America Artificial Intelligence In Precision Medicine Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 106 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Country (2021-2030) ($MN)
  • Table 107 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Offering (2021-2030) ($MN)
  • Table 108 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Hardware (2021-2030) ($MN)
  • Table 109 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Services (2021-2030) ($MN)
  • Table 110 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Software (2021-2030) ($MN)
  • Table 111 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Technology (2021-2030) ($MN)
  • Table 112 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Machine Learning (2021-2030) ($MN)
  • Table 113 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Context-aware Computing (2021-2030) ($MN)
  • Table 114 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Natural Language Processing (2021-2030) ($MN)
  • Table 115 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Computer Vision (2021-2030) ($MN)
  • Table 116 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Querying Method (2021-2030) ($MN)
  • Table 117 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Deep Learning (2021-2030) ($MN)
  • Table 118 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Application (2021-2030) ($MN)
  • Table 119 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 120 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Neurology (2021-2030) ($MN)
  • Table 121 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Cardiology (2021-2030) ($MN)
  • Table 122 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Respiratory (2021-2030) ($MN)
  • Table 123 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Ophthalmology (2021-2030) ($MN)
  • Table 124 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Nephrology (2021-2030) ($MN)
  • Table 125 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Otorhinolaryngology (2021-2030) ($MN)
  • Table 126 Middle East & Africa Artificial Intelligence In Precision Medicine Market Outlook, By Other Applications (2021-2030) ($MN)